U.S. Patent to Protect Buprenorphine Production Process
Press Releases

U.S. Patent to Protect Buprenorphine Production Process

River Stone Biotech Inc. Announces Issuance of U.S. Patent to Protect Their More Efficient Buprenorphine Production Process. Jul. 19, 2022 – River Stone Biotech Inc.(RSB), a synthetic biology business centered […]

Jul 19, 2022
River Stone Biotech Inc. participates in DCAT 2022 conference
Press Releases

River Stone Biotech Inc. participates in DCAT 2022 conference

River Stone Biotech Inc. participates in DCAT 2022 conference and announces its ambition in becoming a global provider of substance abuse APIs. Cambridge, April 28, 2022 – River Stone Biotech […]

Apr 22, 2022
Series B Fundraise Closes
Press Releases

Series B Fundraise Closes

River Stone Biotech Inc. Announces $6.8M Series B Financing to Advance Lead Pipeline Projects To Treat Opiate Use Disorder and Opiate Overdose

Nov 10, 2021
$6.8M Series B Financing to Advance Lead Pipeline Projects
Press Releases

$6.8M Series B Financing to Advance Lead Pipeline Projects

River Stone Biotech Inc. Announces $6.8M Series B Financing to Advance Lead Pipeline Projects To Treat Opiate Use Disorder and Opiate Overdose Cambridge, Nov. 10, 2021 – River Stone Biotech […]

Nov 10, 2021